News
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...
Gov. Mike Braun visited Lebanon Tuesday to help break ground for the $4.5 billion Eli Lilly Medicine Foundry in Lebanon. The foundry is the first research and development site of its kind in the world ...
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...
The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...
6hon MSN
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...
U.S. equities were mixed at midday, with tech shares and a better-than-expected consumer inflation report lifting the S&P 500 ...
Donald Trump has launched a new war, this time against pharmaceutical companies. He has signed an executive order to reduce ...
10h
Pharmaceutical Technology on MSNGLP-1RAs show anti-cancer benefits beyond weight lossGlobalData analysis predicts the global GLP-1RA market will reach $168bn by 2033, with Novo Nordisk and Eli Lilly to dominate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results